ECM stiffness regulates nucleus pulposus stem cell quiescence through PIEZO1-Ca²⁺-NFATC1-CXCL1 signaling axis
Intervertebral disc degeneration (IDD) is a leading cause of chronic low back pain and disability worldwide, yet disease-modifying therapies remain unavailable. Nucleus pulposus stem cells (NPSCs) maintain disc homeostasis through their quiescent state. However, how mechanical microenvironmental alterations, particularly extracellular matrix (ECM) stiffening, govern NPSC quiescence remains poorly understood. We sought to identify the mechanotransduction pathways linking ECM stiffness to NPSC quiescence regulation and explore their relevance in vivo . Human NP tissue analysis, public scRNA-seq reanalysis, 3D rat NPSC culture and rodent models were combined. NPSCs were cultured in GelMA hydrogels with Soft (4.85 kPa) or Stiff (13.80 kPa) compression modulus. Transcriptomic, pharmacological, calcineurin, NFATC1 knockdown and promoter-reporter assays examined the PIEZO1-Ca²⁺-NFATC1-CXCL1 axis. The CXCR1/2 inhibitor Reparixin was tested in vitro and with GelMA-NPSC delivery in a rat nucleotomy model. Piezo1 CKO mice underwent disc puncture to assess the contribution of PIEZO1. scRNA-Seq reanalysis identified an operationally defined NPSC-like population and exploratory evidence of increased cell-cycle engagement during early degeneration, particularly between Pfirrmann grades II and III. Severely degenerated NP tissues exhibited higher compression modulus. In 3D culture, Stiff matrix drove NPSCs out of quiescence with NANOG/SOX2 downregulation, independent of cellular senescence. Bulk RNA-Seq identified Cxcl1 as the most abundant cytokine among the shared inflammatory leading-edge genes. Matrix stiffening increased intracellular Ca²⁺, calcineurin activity and NFATC1 nuclear localization. Tacrolimus reduced calcineurin activity and CXCL1 secretion under Stiff conditions, supporting calcineurin involvement. NFATC1 promoter occupancy, reporter activity and knockdown supported direct regulation of CXCL1 transcription. CXCL1-CXCR1/2 signaling was associated with increased AKT phosphorylation and changes in autophagy-related markers. GsMTx4 or Reparixin restored quiescence-associated markers. In exploratory short-term in vivo analyses, GelMA-NPSC + Reparixin showed greater disc-height preservation and proteoglycan deposition than GelMA-NPSC alone, whereas Piezo1 CKO mice showed higher normalized DHI than controls at the matched puncture level in the primary analysis. These findings support a PIEZO1-Ca²⁺-NFATC1-CXCL1 pathway linking ECM stiffness to NPSC quiescence regulation and provide a rationale for further preclinical evaluation of this axis in early IDD.
Authors
- Zhuolin Yang
- 赵润芝
- Tong Zhu
- Bo Huang
- Hua Deng
- Jiabin Liu
- Hui Xing
- Rong Tang
- Xue Leng
Institutions
- Guiyang Medical University (CN)
- Army Medical University (CN)
- Xinqiao Hospital (CN)
- Chongqing Municipal Health Commission (CN)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1186/s13287-026-05405-7
- Primary Topic
- Spine and Intervertebral Disc Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China